David P. Luci - Feb 13, 2023 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: David P. Luci
Stock symbol
ACXP
Transactions as of
Feb 13, 2023
Transactions value $
$0
Form type
4
Date filed
2/24/2023, 03:31 PM
Previous filing
Jul 29, 2022
Next filing
Jan 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +130K $0.00 130K Feb 13, 2023 Common Stock 130K $3.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 13, 2023 (the " Grant Date"), the Reporting Person was granted stock options to purchase 130,000 shares of the Issuer's common stock. These options vest in 36 equal monthly installments commencing on the Grant Date. This transaction is late due to an inadvertent administrative error and not any error of the Reporting Person.